Table 2.

Hematological management during COVID-19 pandemic

Hematological management		N (%)
During COVID-19 pandemic I come to hematological visits	Personal vehicle or walking	249 (61.8%)
	Public transport	13 (3.2%)
	Taxi	11 (2.7%)
	Accompanied by family	74 (18.4%)
	I do not visit hematological clinic	56 (13.9%)
I was infected with COVID-19		6 (1.5%)
If yes, I was hospitalized		3 (50.0%)
A family member was infected with COVID-19		48 (11.8%)
I was supposed to receive treatment but it was delayed because of COVID-19 pandemic		37 (9.1%)
If yes, delayed by	< 1 week	1 (2.9%)
	1 week to 1 month	13 (37.1%)
	> 1 month	21 (60.0%)
Treatment delay was	In my demand	8 (22.2%)
	Physician decision	13 (36.1%)
	Shared decision	13 (36.1%)
	Other	2 (5.6%)
I was supposed to have bone marrow transplantation but it was delayed because of COVID-19 pandemic		2 (0.5%)
I received an alternative treatment for my hematological disease due to COVID-19 pandemic		9 (2.2%)
If yes, it was	In my demand	1 (16.7%)
	Physician decision	2 (33.3%)
	Shared decision	3 (50.0%)